Fundraising FoxPersonalized Cancer Therapy
Mclean, US · Founded 2011 · Delaware corporation
Find your way into Personalized Cancer Therapy
Sign up to see every warm intro you have to Personalized Cancer Therapy
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Personalized Cancer Therapy team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
AM
Andrew MignattiExecutive
EP
Emanuel PetricoinNamed on SEC filing
Board
MD
M. Dendy YoungBoard director
Reported raises · per SEC filings
Form D private placements$17.9M disclosed across 6 rounds · 2014–2022
▶$4.5MraisedOct 2022 · 15 investors · Other Health CareRule 506(b)
▶$4.5MraisedOct 2022 · 15 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- John Robert WalkerDirector
- Albert T KelleyExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $4.5M
- First sale
- Mar 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.1MraisedJan 2019 · 1 investors · Other Health CareRule 506(b)
▶$2.1MraisedJan 2019 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Neil CallahanDirector
- Federoff HowardDirector
- Gary GregoryExecutive Officer
- Emanuel PetricoinDirector
- Offering amount
- $5M
- Amount sold
- $2.1M
- First sale
- Jan 2019
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$750KraisedDec 2017 · 2 investors · Other Health CareRule 506(b)
▶$750KraisedDec 2017 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Neil CallahanDirector
- Emanuel PetricoinDirector
- Michael Dendy YoungDirector
- Neal KollerExecutive Officer, Director
- Offering amount
- $4M
- Amount sold
- $750K
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$9.2MraisedJul 2016 · 6 investors · Other Health CareRule 506(b)
▶$9.2MraisedJul 2016 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Emanuel PetricoinDirector
- Andrew MignattiExecutive Officer, Director
- Neil CallahanDirector
- M. Dendy YoungExecutive Officer, Director
- Offering amount
- $9.2M
- Amount sold
- $9.2M
- First sale
- Jun 2016
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$100KraisedDec 2015 · 1 investors · Other Health CareRule 506(b)
▶$100KraisedDec 2015 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- M. Dendy YoungExecutive Officer, Director
- Emmanuel PetricoinExecutive Officer, Director
- Andrew MignattiExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $100K
- Minimum investment
- $25K
- Proceeds to insiders
- $100K
- First sale
- Dec 2015
- Incorporated
- Corporation, Virginia, 2011
- Federal exemptions
- 06b
▶$1.3MraisedAug 2015 · 2 investors · Other Health CareRule 506(b)
▶$1.3MraisedAug 2015 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- M. Dendy YoungExecutive Officer, Director
- Andrew MignattiExecutive Officer, Director
- Emanuel PetricoinExecutive Officer, Director
- Offering amount
- $1.4M
- Amount sold
- $1.3M
- Minimum investment
- $25K
- Proceeds to insiders
- $100K
- First sale
- Oct 2014
- Incorporated
- Corporation, Virginia, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Personalized Cancer Therapy raised?
- Personalized Cancer Therapy has disclosed $17.9M raised across 6 rounds.
- Where is Personalized Cancer Therapy headquartered?
- Personalized Cancer Therapy is headquartered in Mclean, US.